Our mitochondrial-targeted gene therapy demonstrates remarkable efficacy against breast cancer. Read our latest study in Cell Reports Medicine! Combine antibody-drug conjugate with cmLumiOpto for triple-negative breast cancer treatment: https://t.co/3umunF0EmN
I am thrilled that our mitochondrial-targeted cancer therapy paper just got published in Cancer Research @AACR!
mLumiOpto Is a Mitochondrial-Targeted Gene Therapy for Treating Cancer https://t.co/GmMKokILW6
.@OhioState researchers are shining a light on cancer cells’ energy centers – literally – to damage these power sources and trigger widespread cancer cell death. A new study showed the therapy shrinks tumors in mice. @OSUEngineering@OSUCCC_James https://t.co/UxE8cgcZtr
Grace Wang, @OhioState’s executive vice president of research, innovation and knowledge, has been named president of Worcester Polytechnic Institute, one of the nation’s first technological universities. @WPI https://t.co/lQF1j98yVz